TAMMIE WALZ: Open Payments
NPI 1679572374 · SAVANNAH, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$248 in 14 payments from 9 companies in 2025. Trend: 2023 $114 · 2024 $53 · 2025 $248
Food & beverage: $248
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 4 | $71 |
| Novo Nordisk Inc | 2 | $36 |
| Dexcom, Inc. | 2 | $28 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $23 |
| Lilly USA, LLC | 1 | $22 |
| Boston Scientific Corporation | 1 | $21 |
| Inspire Medical Systems, Inc. | 1 | $17 |
| Medtronic, Inc. | 1 | $17 |
| AstraZeneca Pharmaceuticals LP | 1 | $14 |
Products named: KRYSTEXXA, Wegovy, Dexcom G6 Transmitter, CAPLYTA, JARDIANCE, General - Pain Management, INSPIRE, INTERSTIM.
Industry payments across GA — which companies pay providers there.
